相似文献
1
Bone marrow cell-based regenerative therapy for liver cirrhosis.
World J Methodol. 2013 Dec 26;3(4):65-9. doi: 10.5662/wjm.v3.i4.65.
2
[Autologous bone marrow cell infusion therapy for liver cirrhosis--now and future].
Rinsho Byori. 2011 Dec;59(12):1092-8.
3
Autologous bone marrow cell infusion therapy for liver cirrhosis patients.
J Hepatobiliary Pancreat Sci. 2011 Jan;18(1):23-5. doi: 10.1007/s00534-010-0305-1.
4
Novel findings for the development of drug therapy for various liver diseases: Current state and future prospects for our liver regeneration therapy using autologous bone marrow cells for decompensated liver cirrhosis patients.
J Pharmacol Sci. 2011;115(3):274-8. doi: 10.1254/jphs.10r13fm. Epub 2011 Feb 22.
5
Bone marrow-derived stem cells in liver repair: 10 years down the line.
Liver Transpl. 2010 Feb;16(2):118-29. doi: 10.1002/lt.21965.
6
Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells.
Tissue Eng Part B Rev. 2014 Jun;20(3):206-10. doi: 10.1089/ten.TEB.2013.0527. Epub 2014 Mar 7.
7
Advanced therapies using autologous bone marrow cells for chronic liver disease.
Discov Med. 2012 Jul;14(74):7-12.
8
Stem cell therapy in chronic liver disease.
Curr Opin Gastroenterol. 2012 May;28(3):203-8. doi: 10.1097/MOG.0b013e3283521d6a.
9
Status of and candidates for cell therapy in liver cirrhosis: overcoming the "point of no return" in advanced liver cirrhosis.
J Gastroenterol. 2017 Feb;52(2):129-140. doi: 10.1007/s00535-016-1258-1. Epub 2016 Sep 8.
10
Bone-marrow-derived cells cultured in serum-free medium reduce liver fibrosis and improve liver function in carbon-tetrachloride-treated cirrhotic mice.
Cell Tissue Res. 2013 Mar;351(3):487-95. doi: 10.1007/s00441-012-1528-z. Epub 2012 Nov 27.
引用本文的文献
1
Autologous bone marrow stem cell transplantation via the hepatic artery for the treatment of hepatitis B virus-related cirrhosis: a PRISMA-compliant meta-analysis based on the Chinese population.
Stem Cell Res Ther. 2020 Mar 5;11(1):104. doi: 10.1186/s13287-020-01627-5.
2
Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis.
Med Sci Monit. 2019 Sep 24;25:7182-7190. doi: 10.12659/MSM.916428.
3
Current Understanding of Stem Cell and Secretome Therapies in Liver Diseases.
Tissue Eng Regen Med. 2017 Nov 20;14(6):653-665. doi: 10.1007/s13770-017-0093-7. eCollection 2017 Dec.
4
Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives.
World J Gastroenterol. 2015 Sep 28;21(36):10253-61. doi: 10.3748/wjg.v21.i36.10253.
5
Autologous mobilized peripheral blood CD34(+) cell infusion in non-viral decompensated liver cirrhosis.
World J Gastroenterol. 2015 Jun 21;21(23):7264-71. doi: 10.3748/wjg.v21.i23.7264.
本文引用的文献
1
Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy.
J Gastroenterol. 2012 May;47(5):491-7. doi: 10.1007/s00535-012-0580-5. Epub 2012 Apr 5.
2
Matrix metalloproteinases (MMPs) activity in cultured canine bone marrow stromal cells (BMSCs).
J Vet Med Sci. 2012 May;74(5):633-6. doi: 10.1292/jvms.11-0395. Epub 2011 Dec 13.
3
Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells.
Eur J Gastroenterol Hepatol. 2011 Oct;23(10):936-41. doi: 10.1097/MEG.0b013e3283488b00.
4
Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes.
Hepatology. 2011 Sep 2;54(3):820-8. doi: 10.1002/hep.24434. Epub 2011 Jul 14.
5
Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis.
Stem Cells Dev. 2011 Sep;20(9):1503-10. doi: 10.1089/scd.2011.0074. Epub 2011 May 11.
6
Enhanced expression of fibroblast growth factor 2 in bone marrow cells and its potential role in the differentiation of hepatic epithelial stem-like cells into the hepatocyte lineage.
Cell Tissue Res. 2011 Feb;343(2):371-8. doi: 10.1007/s00441-010-1093-2. Epub 2010 Dec 9.
7
Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis.
Cell Transplant. 2010;19(10):1237-46. doi: 10.3727/096368910X506863. Epub 2010 Jun 3.
8
Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.
Eur J Gastroenterol Hepatol. 2009 Oct;21(10):1199-205. doi: 10.1097/MEG.0b013e32832a1f6c.
9
Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis.
Am J Gastroenterol. 2008 Aug;103(8):1952-8. doi: 10.1111/j.1572-0241.2008.01993.x. Epub 2008 Jul 12.
10
Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy.
Cytotherapy. 2008;10(4):390-6. doi: 10.1080/14653240802129901.
Zotero 插件